NDSI
VRTX icon

Newman Dignan & Sheerar Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
871
+79
+10% +$35K 0.08% 138
2026
Q1 		$354K Buy
792
+13
+2% +$6.06K 0.07% 147
2025
Q4 		$353K Sell
779
-37
-5% -$15.9K 0.07% 145
2025
Q3 		$320K Buy
816
+30
+4% +$12.5K 0.07% 151
2025
Q2 		$350K Buy
786
+25
+3% +$11.5K 0.08% 142
2025
Q1 		$369K Buy
761
+31
+4% +$14.4K 0.1% 122
2024
Q4 		$294K Sell
730
-36
-5% -$16.7K 0.08% 142
2024
Q3 		$365K Buy
766
+2
+0.3% +$961 0.09% 133
2024
Q2 		$358K Sell
764
-33
-4% -$14.3K 0.09% 132
2024
Q1 		$333K Hold
797
– – 0.09% 141
2023
Q4 		$324K Buy
797
+34
+4% +$12.6K 0.1% 133
2023
Q3 		$265K Buy
763
+5
+0.7% +$1.75K 0.09% 140
2023
Q2 		$267K Sell
758
-135
-15% -$45.5K 0.08% 152
2023
Q1 		$281K Sell
893
-10
-1% -$3K 0.09% 154
2022
Q4 		$261K Hold
903
– – 0.09% 157
2022
Q3 		$261 Hold
903
– – 0.04% 150
2022
Q2 		$254K Hold
903
– – 0.09% 163
2022
Q1 		$236 Sell
903
-20
-2% -$4.75K 0.05% 171
2021
Q4 		$203K Sell
923
-335
-27% -$65.1K 0.06% 190
2021
Q3 		$228K Buy
1,258
+5
+0.4% +$976 0.07% 172
2021
Q2 		$253K Sell
1,253
-80
-6% -$16.7K 0.09% 161
2021
Q1 		$286K Buy
+1,333
New +$293K 0.1% 149

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Newman Dignan & Sheerar Inc's VRTX Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc increased its Vertex Pharmaceuticals (VRTX) stake by 10% in Q2 2026, buying an estimated $35K and bringing the position to 871 shares worth $433K. The position accounts for 0.08% of the portfolio, ranked #138.

Newman Dignan & Sheerar Inc first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 871 shares of Vertex Pharmaceuticals worth $433K as of Q2 2026.
  • Newman Dignan & Sheerar Inc bought 79 Vertex Pharmaceuticals shares in Q2 2026, an estimated $35K.
  • Vertex Pharmaceuticals made up 0.08% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #138 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.